Our funding is primarily directed towards the following two areas and roughly apportioned accordingly:
To date, all our research funding has supported translational and conceptual (out-of-the-box) research at regional National Cancer Institute-designated (NCI-designated) facilities with strong translational research programs. General research funding from grassroots organizations like ours is essential and critical to maintaining research focused on translational findings and the early explorations of concepts and ideas that could lead to breakthroughs. In addition to returns on translational advancements, funding like ours supports the necessary research for proof-of-concept data required to secure larger grants for further research and clinical trials; some of which could later be game-changing.
Our compassionate care funding is directed towards local and regional institutions providing treatment and care to pancreatic cancer patients and sometimes their primary caregivers. The funding can be quickly disbursed by our ‘partner’ institutions to aid patients and their caregivers who due to the nature of the disease and/or accompanying treatment, both of which can be debilitating and life-changing, find themselves in situations of great need. Examples of compassionate care funding use could include, but not be limited to the following: